HSIC / Henry Schein, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Henry Schein, Inc.
US ˙ NasdaqGS ˙ US8064071025

Mga Batayang Estadistika
LEI VGO3WGL8H45T73F4RR92
CIK 1000228
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Henry Schein, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 5, 2025 8-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

August 5, 2025 10-Q

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

August 5, 2025 EX-99.1

HENRY SCHEIN REPORTS SECOND

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS ● Second-quarter 2025 GAAP diluted EPS of $0.

August 5, 2025 EX-10.3

Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and

Exhibit 10.3 HENRY SCHEIN, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AMENDED AND RESTATED EFFECTIVE AS OF SEPTEMBER 1, 2025 The Plan was originally established, effective as of January 1, 1994, and was amended and restated effective as of February 9, 1998, March 1, 2005, January 1, 2008, and January 1, 2014, with the adoption of amendments from time to time, to provide deferred compensation to a

July 15, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 Henry Schein, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

July 15, 2025 EX-99.1

Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 Mr. Bergman to Continue to Serve as Chairman of the Board

Exhibit 99.1 FOR IMMEDIATE RELEASE Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 Mr. Bergman to Continue to Serve as Chairman of the Board MELVILLE, N.Y., July 15, 2025 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will r

June 20, 2025 11-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11 -K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

June 9, 2025 EX-10.1

administrative agent and joint lead arranger, U.S. Bank National Association, as

Exhibit 10.1 Execution Version $750,000,000 AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT among HENRY SCHEIN, INC., as Borrower, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK NATIONAL ASSOCIATION, as Syndication Agent, Dated as of June 6, 2025 JPMORGAN CHASE BANK, N.A. and U.S. BANK NATIONAL ASSOCIATION, as Joint Lead Arrangers and Joint Bookru

June 9, 2025 EX-10.2

2025, among us, the several lenders parties thereto, and JPMorgan Chase Bank,

Exhibit 10.2 Execution Version $1,000,000,000 THIRD AMENDED AND RESTATED CREDIT AGREEMENT among HENRY SCHEIN, INC., as Parent Borrower, The Other Subsidiary Borrowers from Time to Time Parties Hereto, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK NATIONAL ASSOCIATION, as Syndication Agent, THE TORONTO-DOMINION BANK, NEW YORK BRANCH, BANK OF AMERI

June 9, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 Henry Schein, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 30, 2025 SD

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 23, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 16, 2025 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): May 16, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

May 16, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

May 16, 2025 EX-99.1

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

Exhibit 99.1 Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors MELVILLE, N.Y., May 16th, 2025 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliat

May 5, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

May 5, 2025 10-Q

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEI

May 5, 2025 EX-99.2

Form of 2025 Restricted Stock Unit Agreement for time-based restricted stock

Exhibit 99.2 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2024 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2024) THIS AGREEMENT (the “Agreement”) is made as of [Grant Date] (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and [Participant Name] (the “Participant”). Additional country-specific and state-specific terms and

May 5, 2025 EX-10.4

Henry Schein, Inc. Incentive Plan and Plan Summary, effective as of January 1,

Exhibit 10.4 Henry Schein, Inc. Incentive Plan and Plan Summary Amended and Restated as of January 1, 2025 1. Introduction As a member of the management team of Henry Schein, Inc. or its affiliates (the “Company”), you have a direct impact on the Company’s profitability. To align your interest with that of the Company, you have been nominated to participate in the Henry Schein, Inc. Incentive Plan

May 5, 2025 EX-99.1

HENRY SCHEIN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS ● First-quarter 2025 GAAP diluted EPS of $0.

May 5, 2025 EX-99.1

Letter Agreement on Share Repurchases by and between us and KKR Hawaii

Exhibit 99.1 CONFIDENTIAL March 6, 2025 VIA E-MAIL Henry Schein, Inc. 135 Duryea Road Melville, New York 11747 Attention: Walter Siegel, Kelly Murphy Email: [*** - personal information] KKR Hawaii Aggregator L.P. c/o Kohlberg Kravis Roberts & Co. L.P. Sand Hill Road, Suite 200 Menlo Park, CA 94025 Attention: Hunter Craig and Max Lin Email: [*** - personal information] Re: Strategic Partnership Agr

May 5, 2025 EX-99.3

restricted stock unit awards pursuant to the Henry Schein, Inc. 2024 Stock

Exhibit 99.3 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2024 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2024) THIS AGREEMENT (the “Agreement”) is made as of [Grant Date] (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and [Participant Name] (the “Participant”). Additional country-specific and state-specific terms and

May 2, 2025 EX-10.1

Hawaii Aggregator L.P. (Incorporated by reference to Exhibit 10.1 to our

EX-10.1 Exhibit 10.1 May 2, 2025 VIA E-MAIL Henry Schein, Inc. 135 Duryea Road Melville, New York 11747 Attention: Walter Siegel, Kelly Murphy Email: [*** - personal information] KKR Hawaii Aggregator L.P. c/o Kohlberg Kravis Roberts & Co. L.P. Sand Hill Road, Suite 200 Menlo Park, CA 94025 Attention: Hunter Craig and Max Lin Email: [*** - personal information] Re: Voting Commitment Dear Sirs and

May 2, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

May 2, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): May 2, 2025 Henry Schein, Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): May 2, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File N

April 15, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): April 10, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission Fil

April 15, 2025 EX-10.2

Amended and Restated Henry Schein, Inc. Executive Change in Control Plan

Exhibit 10.2 HENRY SCHEIN, INC. EXECUTIVE CHANGE IN CONTROL PLAN As Amended and Restated Effective as of April 10, 2025 1. Introduction. The purpose of the Henry Schein, Inc. Executive Change in Control Plan, as amended and restated effective as of April 10, 2025 (the “Plan”), is to provide assurances of specified benefits to executive-level employees of Henry Schein, Inc. (“HSI” or the “Company”)

April 15, 2025 EX-10.1

Exhibit 10.1 to our Current Report on Form 8-K filed on April 15, 2025.)**

EXHIBT 10.1 HENRY SCHEIN, INC. EXECUTIVE SEVERANCE PLAN Effective as of April 10, 2025 1. Introduction. The purpose of the Henry Schein, Inc. Executive Severance Plan (the “Plan”) is to provide specified benefits to executive-level employees of Henry Schein, Inc. (“HSI” or the “Company”) who are eligible to participate as set forth under the Plan and who are members of a select group of management

April 9, 2025 EX-10.1

Aggregator L.P. (Incorporated by reference to Exhibit 10.1 to our Current

Exhibit 10.1 April 7, 2025 VIA E-MAIL Henry Schein, Inc. 135 Duryea Road Melville, New York 11747 Attention: Walter Siegel, Kelly Murphy Email: [*** - personal information] KKR Hawaii Aggregator L.P. c/o Kohlberg Kravis Roberts & Co. L.P. Sand Hill Road, Suite 200 Menlo Park, CA 94025 Attention: Hunter Craig and Max Lin Email: [*** - personal information] Re: Voting Commitment Dear Sirs and Madams

April 9, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): April 7, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

April 9, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ 

April 9, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  ☑ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy Sta

March 14, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): March 11, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission Fil

February 25, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

February 25, 2025 EX-99.1

HENRY SCHEIN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

EX-99.1 2 exhibit991.htm PRESS RELEASE FEBRUARY 25, 2025 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES DETAILED 2025 FINANCIAL GUIDANCE ● Fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19 ● Fourth-quarter 2024 operating cash flow of $204 million; full-year 2024 operating cash flow of $848 million,

February 25, 2025 EX-19.1

Henry Schein, Inc. Insider Trading Policy (amended and restated as of January 1, 2025)+

Exhibit 19.1 INSIDER TRADING POLICY (amended and restated as of January 1, 2025) 1. Purpose To prevent the misuse of material, non-public information about Henry Schein, Inc. or any majority-owned entity (e.g., subsidiary, joint venture and/or affiliate) (collectively referred to herein as the “Company”) or about other companies obtained by virtue of your position at the Company. 2. Scope Key term

February 25, 2025 EX-99.4

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

Exhibit 99.4 AMENDMENT NO. 12 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 12 TO RECEIVABLES PURCHASE AGREEMENT, dated as of December 6, 2024 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), the PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), the PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchaser

February 25, 2025 10-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-27078 HENRY SCHEIN, INC. (

February 25, 2025 EX-21.1

List of our Subsidiaries.+

Exhibit 21.1 List of Subsidiaries Subsidiary Jurisdiction of incorporation or organization ACE Surgical Supply Co., Inc. Massachusetts BioHorizons, Inc.1 Delaware Camlog USA, Inc.2 Delaware eAssist, Inc.3 Wyoming Exan Enterprises Inc.4 Nevada Handpiece Parts & Repairs, Inc. Delaware Henry Schein (Lancaster, PA) Inc. Pennsylvania Henry Schein Europe, Inc.5 Delaware Henry Schein Global Sourcing, Inc

January 29, 2025 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of the report (Date of earliest event reported): January 29, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission F

January 29, 2025 EX-10.2

Form of Registration Rights Agreement

Exhibit 10.2 FORM OF REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of [•], 2025 (the “Agreement”), by and among Henry Schein, Inc., a Delaware corporation (the “Company”), and KKR Hawaii Aggregator L.P., a Delaware limited partnership (the “Investor”). The Investor and any other party that may become a party hereto pursuant to Section 10(c) are referred to collectively as t

January 29, 2025 EX-10.1

Hawaii Aggregator L.P. (Incorporated by reference to Exhibit 10.1 to our Current Report

Exhibit 10.1 STRATEGIC PARTNERSHIP AGREEMENT by and among HENRY SCHEIN, INC., and KKR Hawaii Aggregator L.P. Dated as of January 29, 2025 TABLE OF CONTENTS PAGE ARTICLE I Definitions 1 Section 1.01 Definitions 1 ARTICLE II Purchase and Sale 6 Section 2.01 Purchase and Sale 6 Section 2.02 Closing 6 ARTICLE III Representations and Warranties of the Company 7 Section 3.01 Organization; Standing 7   

January 29, 2025 EX-99.1

HENRY SCHEIN ANNOUNCES STRATEGIC INVESTMENT BY KKR, BOARD CHANGES AND PROVIDES PRELIMINARY UNAUDITED FINANCIAL RESULTS AND 2025 FINANCIAL GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES STRATEGIC INVESTMENT BY KKR, BOARD CHANGES AND PROVIDES PRELIMINARY UNAUDITED FINANCIAL RESULTS AND 2025 FINANCIAL GUIDANCE • KKR to become 12% common shareholder in Henry Schein • Henry Schein and KKR to collaborate on range of value creation opportunities • Two KKR representatives with deep sector experience to join the Henry Schein Board

December 13, 2024 S-8

As filed with the Securities and Exchange Commission on December 13, 2024

As filed with the Securities and Exchange Commission on December 13, 2024 Registration No.

December 13, 2024 EX-FILING FEES

Filing Fee Table*

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Henry Schein, Inc.

December 13, 2024 S-8

As filed with the Securities and Exchange Commission on December 13, 2024

As filed with the Securities and Exchange Commission on December 13, 2024 Registration No.

December 13, 2024 EX-FILING FEES

Filing Fee Table*

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Henry Schein, Inc.

November 13, 2024 SC 13G/A

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

SC 13G/A 1 generation-hsic093024a8.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* Henry Schein, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 806407102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check th

November 12, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d839680dex991.htm EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 11/12/2024 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTI

November 12, 2024 SC 13G

HSIC / Henry Schein, Inc. / Artisan Partners Limited Partnership - SC 13G Passive Investment

SC 13G 1 d839680dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. Under the Securities Exchange Act of 1934 (Amendment No.   )* Henry Schein Inc. (Name of Issuer) Common Stock (Title of Class o

November 5, 2024 10-Q

December 24, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 28, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY S

November 5, 2024 EX-99.1

HENRY SCHEIN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND INCREASES 2024 FINANCIAL GUIDANCE ● Third-quarter 2024 GAAP diluted EPS of $0.

November 5, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2024 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-

October 7, 2024 CORRESP

2

October 7, 2024 United States Securities and Exchange Commission Division of Corporation Finance Disclosure Review Program 100 F Street N.

September 10, 2024 CORRESP

2

September 10, 2024 United States Securities and Exchange Commission Division of Corporation Finance Disclosure Review Program 100 F Street N.

August 6, 2024 EX-99.1

as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as agent

Exhibit 99.1 AMENDMENT NO. 11 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 11 TO RECEIVABLES PURCHASE AGREEMENT, dated as of May 17, 2024 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), the PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), the PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchaser Agen

August 6, 2024 EX-99.1

HENRY SCHEIN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND UPDATES 2024 FINANCIAL GUIDANCE Highlights: ● Second-quarter 2024 GAAP diluted EPS of $0.

August 6, 2024 8-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

August 6, 2024 10-Q

December 24, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

June 21, 2024 11-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11 -K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

May 29, 2024 SD

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 24, 2024 EX-10.1

Henry Schein, Inc. 2024 Stock Incentive Plan, as amended and restated effective as of May 21, 2024

Exhibit 10.1 HENRY SCHEIN, INC. 2024 STOCK INCENTIVE PLAN As Amended and Restated Effective as of May 21, 2024 1. Purposes of the Plan The purposes of this Henry Schein, Inc. 2024 Stock Incentive Plan, as amended and restated effective as of May 21, 2024, are to enable HSI and its Subsidiaries (each as defined herein) to attract, retain and motivate the Key Employees and Consultants (each as defin

May 24, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2024 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 7, 2024 EX-99.1

HENRY SCHEIN REPORTS SOLID FIRST-QUARTER

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SOLID FIRST-QUARTER 2024 FINANCIAL RESULTS AND UPDATES 2024 FINANCIAL GUIDANCE ● First-quarter 2024 sales growth of 3.

May 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

May 7, 2024 EX-10.3

restated effective as of May 21, 2020). (Incorporated by reference to Exhibit 10.3 to our

Exhibit 10.3 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the “Agreement”) is made as of [Grant Date] (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and [Participant Name] (the “Participant”). Additional country-specific and state-specific terms and

May 7, 2024 EX-10.2

effective as of May 21, 2020). (Incorporated by reference to Exhibit 10.2 to our Quarterly

Exhibit 10.2 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the “Agreement”) is made as of [Grant Date] (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and [Participant Name] (the “Participant”). Additional country-specific and state-specific terms and

May 7, 2024 EX-10.1

Henry Schein, Inc. Incentive Plan and Plan Summary, effective as of January 1,

Exhibit 10.1 Henry Schein, Inc. Incentive Plan and Plan Summary Amended and Restated as of January 1, 2024 1. Introduction As a member of the management team, you have direct impact to the profitability of Henry Schein. To align your interest with that of the Company, you have been nominated to participate in the Henry Schein Incentive Plan (formerly the Performance Incentive Plan), as may be amen

May 7, 2024 10-Q

December 24, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEI

May 7, 2024 EX-10.4

amended and restated effective as of May 23, 2023). (Incorporated by reference to Exhibit

Exhibit 10.4 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2023 NON-EMPLOYEE DIRECTOR STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF May 23, 2023) THIS AGREEMENT (the “Agreement”) made as of [Grant Date] (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and [Participant Name] (the “Participant”). W I T N E S S E T H: WHEREAS, the Comp

April 10, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box:   ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Sta

April 10, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ 

February 28, 2024 EX-99.1

Limited Waiver dated November 10, 2023 to the Multicurrency Private Shelf Agreement,

Exhibit 99.1 AIG Asset Management (U.S.), LLC 2929 Allen Parkway, 36th Floor Houston, TX 77019 November 10, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Multicurrency Private Shelf Agreement, dated as of October 20, 2021 (as amended, restated, amended

February 28, 2024 EX-99.2

Multicurrency Master Note Purchase Agreement, dated as of October 20, 2021, by and

Exhibit 99.2 METLIFE INVESTMENT MANAGEMENT LIMITED METLIFE INVESTMENT MANAGEMENT, LLC One MetLife Way Whippany, NJ, 07981 November 10, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Third Amended and Restated Multicurrency Master Note Purchase Agreement

February 28, 2024 EX-99.5

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

Exhibit 99.5 MUFG BANK, LTD. (F/K/A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.) 1251 Avenue of the Americas, 12th Floor New York, NY 10020-1104 November 10, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Receivables Purchase Agreement, dated as of April 17,

February 28, 2024 EX-99.7

JPMorgan Chase Bank, N.A., as administrative agent, and the other parties from time to

Exhibit 99.7 JPMorgan Chase Bank, N.A. 131 S Dearborn St, Floor 04 Chicago, IL, 60603-5506 November 14, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Term Loan Credit Agreement, dated as of July 11, 2023 (as amended, restated, amended and restated, sup

February 28, 2024 EX-99.3

Note Facility, dated as of October 20, 2021, by and among us, NYL Investors LLC and

Exhibit 99.3 New York Life Insurance Company c/o NYL Investors LLC 51 Madison Avenue 2nd Floor, Room 208 New York, New York 10010 November 10, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Third Amended and Restated Master Note Facility, dated as of Oc

February 28, 2024 EX-99.6

Revolving Credit Agreement, dated as of July11, 2023, among us, the several lenders from

Exhibit 99.6 JPMorgan Chase Bank, N.A. 131 S Dearborn St, Floor 04 Chicago, IL, 60603-5506 November 14, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Second Amended and Restated Credit Agreement, dated as of July 11, 2023 (as amended, restated, amended

February 28, 2024 EX-99.8

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

Exhibit 99.8 AMENDMENT NO. 9 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 9 TO RECEIVABLES PURCHASE AGREEMENT, dated as of December 20, 2023 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), the PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), the PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchaser A

February 28, 2024 EX-21.1

List of our Subsidiaries.+

Exhibit 21.1 List of Subsidiaries Subsidiary Jurisdiction of incorporation or organization ACE Surgical Supply Co., Inc.1 Massachusetts BioHorizons, Inc.2 Delaware Camlog USA, Inc.3 Delaware eAssist, Inc.4 Wyoming Exan Enterprises Inc.5 Nevada Handpiece Parts & Repairs, Inc. Delaware Henry Schein (Lancaster, PA) Inc. Pennsylvania Henry Schein Europe, Inc.6 Delaware Henry Schein Global Sourcing, In

February 28, 2024 EX-99.4

Multicurrency Private Shelf Agreement, dated as of October 20, 2021, by and among us,

Exhibit 99.4 The Prudential Insurance Company of America c/o PGIM, Inc. Prudential Tower 655 Broad Street 14th Floor- South Tower Newark, NJ 07102 November 10, 2023 Henry Schein Inc. 135 Duryea Road Melville, New York, 11747 Attn: Michael Amodio, Vice President and Treasurer Limited Waiver Ladies and Gentlemen: Reference is hereby made to that certain Third Amended and Restated Multicurrency Priva

February 28, 2024 EX-99.9

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

Exhibit 99.9 AMENDMENT NO. 10 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 10 TO RECEIVABLES PURCHASE AGREEMENT, dated as of February 23, 2024 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), the PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), the PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchaser

February 28, 2024 EX-97.1

Henry Schein, Inc. Dodd-Frank Clawback Policy, effective as of December 1, 2023.**+

Exhibit 97.1 HENRY SCHEIN, INC. DODD-FRANK CLAWBACK POLICY (Effective as of December 1, 2023) Introduction The Board of Directors (the “Board”) of Henry Schein, Inc. (the “Company”) believes it to be in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability, reinforces the Company’s pay for performance compensation philo

February 28, 2024 10-K

HENRY SCHEIN INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-27078 HENRY SCHEIN, INC. (

February 27, 2024 EX-99.1

HENRY SCHEIN REPORTS FOURTH-QUARTER AND FULL-YEAR 2023 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH-QUARTER AND FULL-YEAR 2023 FINANCIAL RESULTS AND INTRODUCES 2024 FINANCIAL GUIDANCE ● Fourth quarter GAAP diluted EPS of $0.

February 27, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

February 14, 2024 SC 13G/A

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

February 13, 2024 SC 13G/A

HSIC / Henry Schein, Inc. / Longview Partners (Guernsey) LTD - LONGVIEW PARTNERS (GUERNSEY) LIMITED Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* Henry Schein, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) US8064071025 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

February 13, 2024 SC 13G/A

HSIC / Henry Schein, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01106-henryscheininc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Henry Schein Inc Title of Class of Securities: Common Stock CUSIP Number: 806407102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate t

December 18, 2023 EX-99.1

HENRY SCHEIN APPOINTS CAROLE T. FAIG AS NEW INDEPENDENT DIRECTOR

Exhibit 99.1 HENRY SCHEIN APPOINTS CAROLE T. FAIG AS NEW INDEPENDENT DIRECTOR MELVILLE, N.Y., December 18, 2023 — Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stock

December 18, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

December 18, 2023 EX-10.1

Plan, amended and restated effective as of January 1, 2014. (Incorporated by reference to

Exhibit 10.1 AMENDMENT NUMBER FOUR TO THE HENRY SCHEIN, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2014 WHEREAS, Henry Schein, Inc. (the “Company”) maintains the Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and restated effective as of January 1, 2014, and as subsequently amended (the “Plan”); WHEREAS, pursuant to Section 16 of

November 28, 2023 10-Q

January 20, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY S

November 16, 2023 EX-99.1

HENRY SCHEIN ANNOUNCES RECEIPT OF DEFICIENCY NOTICE FROM NASDAQ REGARDING REQUIREMENT TO TIMELY FILE QUARTERLY REPORT ON FORM 10-Q

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES RECEIPT OF DEFICIENCY NOTICE FROM NASDAQ REGARDING REQUIREMENT TO TIMELY FILE QUARTERLY REPORT ON FORM 10-Q MELVILLE, N.Y., November 16, 2023 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announces that it received an expected notice (the

November 16, 2023 EX-10.1

Henry Schein, Inc. Deferred Compensation Plan, as amended and restated effective as of

EX-10.1 Exhibit 10.1 HENRY SCHEIN, INC. DEFERRED COMPENSATION PLAN Amended and Restated Effective as of November 14, 2023 ARTICLE 1—INTRODUCTION 1.1 Purpose of Plan Henry Schein, Inc. has adopted the Plan set forth herein to provide a means by which certain employees of Henry Schein, Inc. and certain Associated Companies (as defined herein) can elect to defer receipt of designated percentages of B

November 16, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Henry Schein, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

November 13, 2023 8-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

November 13, 2023 EX-99.1

HENRY SCHEIN REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS AND UPDATES

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL-YEAR GUIDANCE ● GAAP diluted EPS of $1.

November 2, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

November 2, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):  ☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q ☐ Form N-SAR  ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transitio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):  ☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q ☐ Form N-SAR  ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended:            Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

November 2, 2023 EX-99.1

HENRY SCHEIN TO WEBCAST THIRD QUARTER 2023 CONFERENCE CALL AND PROVIDE AN UPDATE ON ITS FULL-YEAR 2023 GUIDANCE ON MONDAY, NOVEMBER 13, 2023 AT 10:00 A.M. ET

Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN TO WEBCAST THIRD QUARTER 2023 CONFERENCE CALL AND PROVIDE AN UPDATE ON ITS FULL-YEAR 2023 GUIDANCE ON MONDAY, NOVEMBER 13, 2023 AT 10:00 A.M. ET MELVILLE, N.Y., November 2, 2023 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will rele

October 25, 2023 CORRESP

1

October 25, 2023 VIA ELECTRONIC TRANSMISSION Amy Geddes Theresa Brillant Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

October 24, 2023 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

October 16, 2023 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

October 16, 2023 EX-99.1

Henry Schein Provides Information on Cybersecurity Incident

Exhibit 99.1 Henry Schein Provides Information on Cybersecurity Incident MELVILLE, NEW YORK — On Saturday, October 14, Henry Schein, Inc. (Nasdaq: HSIC) determined that a portion of its manufacturing and distribution businesses experienced a cybersecurity incident. Henry Schein promptly took precautionary action, including taking certain systems offline and other steps intended to contain the inci

September 28, 2023 CORRESP

September 28, 2023

GENERAL BUSINESS: 1-631-843-5500 FAX: 1 -631 -843-5680 www.henryschein.com September 28, 2023 VIA ELECTRONIC TRANSMISSION Amy Geddes Theresa Brillant Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re:   Henry Schein, Inc. Form 10-K for Fiscal Year Ended Decemb

August 7, 2023 8-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

August 7, 2023 10-Q

January 20, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN,

August 7, 2023 EX-99.1

HENRY SCHEIN REPORTS SOLID SECOND-QUARTER 2023 FINANCIAL RESULTS AND AFFIRMS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SOLID SECOND-QUARTER 2023 FINANCIAL RESULTS AND AFFIRMS FULL-YEAR GUIDANCE ● Achieved internal sales growth of 3.

July 13, 2023 EX-10.2

administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank,

EX-10.2 Exhibit 10.2 Execution Version $1,000,000,000 SECOND AMENDED AND RESTATED CREDIT AGREEMENT among HENRY SCHEIN, INC., as Parent Borrower, The Other Subsidiary Borrowers from Time to Time Parties Hereto, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK NATIONAL ASSOCIATION, as Syndication Agent, TD BANK, N.A., BANK OF AMERICA, N.A., UNICREDIT

July 13, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2023 Henry Schein, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

July 13, 2023 EX-99.1

HENRY SCHEIN ENHANCES LIQUIDITY POSITION WITH NEW $750 MILLION CREDIT FACILITY Amends Existing $1 Billion Credit Facility, Bringing Total Liquidity to $1.8 Billion

EX-99.1 Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE HENRY SCHEIN ENHANCES LIQUIDITY POSITION WITH NEW $750 MILLION CREDIT FACILITY Amends Existing $1 Billion Credit Facility, Bringing Total Liquidity to $1.8 Billion MELVILLE, N.Y., July 13, 2023 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical professionals, today ann

July 13, 2023 EX-10.1

Term Loan Credit Agreement, dated as of July 11, 2023, among us, the several lenders

EX-10.1 Exhibit 10.1 Execution Version $750,000,000 TERM LOAN CREDIT AGREEMENT among HENRY SCHEIN, INC., as Borrower, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK NATIONAL ASSOCIATION, as Syndication Agent, Dated as of July 11, 2023 JPMORGAN CHASE BANK, N.A. and U.S. BANK NATIONAL ASSOCIATION, as Joint Lead Arrangers and Joint Bookrunners TD BAN

June 23, 2023 11-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11 -K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

May 25, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 Henry Schein, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 25, 2023 SD

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 25, 2023 EX-10.1

restated effective as of May 23, 2023. (Incorporated by reference to Exhibit 10.1 to our

EX-10.1 Exhibit 10.1 HENRY SCHEIN, INC. 2023 NON-EMPLOYEE DIRECTOR STOCK INCENTIVE PLAN As Amended and Restated Effective as of May 23, 2023 1. PURPOSE OF THE PLAN The purposes of this Henry Schein, Inc. 2023 Non-Employee Director Stock Incentive Plan, as amended and restated effective as of May 23, 2023, are to enable Henry Schein, Inc. (the “Company”) to attract, retain and motivate directors of

May 9, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

May 9, 2023 10-Q

January 20, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

May 9, 2023 EX-99.1

HENRY SCHEIN REPORTS FIRST-QUARTER

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS ● First-quarter 2023 net sales of $3.

April 11, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State

April 11, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

March 24, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Henry Schein, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Nu

March 24, 2023 EX-3.1

Fourth Amended and Restated By-Laws of Henry Schein, Inc., effective March 23, 2023.

EX-3.1 Exhibit 3.1 BY-LAWS OF HENRY SCHEIN, INC. (a Delaware Corporation) (as amended and restated as of March 23, 2023) FOURTH AMENDED AND RESTATED BY-LAWS OF HENRY SCHEIN, INC. ARTICLE I. OFFICES A registered office shall be established and maintained in the State of Delaware as required by law. The Corporation may have an office or offices, either within or without the State of Delaware, at suc

February 27, 2023 EX-99.1

HENRY SCHEIN, INC. TO DETAIL STRATEGIC PLAN AND LONG-TERM FINANCIAL GOALS AT INVESTOR MEETING

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN, INC. TO DETAIL STRATEGIC PLAN AND LONG-TERM FINANCIAL GOALS AT INVESTOR MEETING MELVILLE, N.Y., February 27, 2023 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, is hosting an Investor Meeting today in New York City at 9 a.m. EST, where executive lea

February 27, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Henry Schein, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

February 21, 2023 EX-10.29

Special Incentive Plan dated May 24, 2021 between Henry Schein, Inc. and Brad

Exhibit 10.29 Certain identified information has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential. [***] INDICATES THE REDACTED PORTION OF THIS EXHIBIT. Interoffice Memorandum To: Brad Connett From: Gerry Benjamin Date: May 13, 2021 Subject: Special Incentive Plan I am pleased to inform you that the Compensation Co

February 21, 2023 EX-10.27

(Incorporated by reference to Exhibit 10.27 to our Annual Report on Form 10-K for the

Exhibit 10.27 November 11, 2021 Dear Brad, Congratulations! On behalf of Henry Schein, Inc., this letter will serve to confirm your promotion to the position of Chief Executive Officer, North America Distribution Group, reporting to Stanley Bergman, Chairman and CEO, Henry Schein, Inc. , Effective date: 09/15/2021. This letter will confirm the following salary adjustment effective 9/15/2021: Base

February 21, 2023 10-K

HENRY SCHEIN INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-27078 HENRY SCHEIN, INC. (

February 21, 2023 EX-21.1

List of our Subsidiaries.+

Exhibit 21.1 List of Subsidiaries Subsidiary Jurisdiction of incorporation or organization ACE Surgical Supply Co., Inc.1 Massachusetts BioHorizons, Inc.2 Delaware Camlog USA, Inc.3 Delaware eAssist, Inc.4 Wyoming Exan Enterprises Inc.5 Nevada Handpiece Parts & Repairs, Inc. Delaware Henry Schein (Lancaster, PA) Inc. Pennsylvania Henry Schein Europe, Inc.6 Delaware Henry Schein Global Sourcing, In

February 21, 2023 EX-10.28

Agreement dated November 11, 2021 between Henry Schein, Inc. and Brad

EX-10.28 8 exhibit1028.htm EXHIBIT 10.28 Exhibit 10.28 AGREEMENT THIS AGREEMENT (“Agreement”) dated November 11, 2021 (the “Effective Date”) is between Henry Schein, Inc., a Delaware corporation (the “Company”) whose principal place of business is 135 Duryea Road, Melville, N.Y., and Bradford C. Connett (“Employee”). WHEREAS, Employee is and has recently been President of the U.S. Medical Group of

February 21, 2023 EX-10.45

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

Exhibit 10.45 AMENDMENT NO. 8 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 8 TO RECEIVABLES PURCHASE AGREEMENT, dated as of December 15, 2022 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), the PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), the PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchaser

February 16, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2023 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

February 16, 2023 EX-99.1

HENRY SCHEIN REPORTS FOURTH-QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS AND

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH-QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS AND INTRODUCES 2023 FINANCIAL GUIDANCE ● Fourth-quarter net sales of $3.

February 13, 2023 SC 13G/A

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

SC 13G/A 1 generation-hsic123122a6.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Henry Schein, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 806407102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the

February 9, 2023 SC 13G/A

HSIC / Henry Schein, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01068-henryscheininc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Henry Schein Inc. Title of Class of Securities: Common Stock CUSIP Number: 806407102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate

February 8, 2023 SC 13G/A

HSIC / Henry Schein, Inc. / Longview Partners (Guernsey) LTD - LONGVIEW PARTNERS (GUERNSEY) LIMITED Passive Investment

SC 13G/A 1 hsica520823.htm LONGVIEW PARTNERS (GUERNSEY) LIMITED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Henry Schein, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) US8064071025 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check th

November 29, 2022 EX-10.1

between Henry Schein, Inc. and Stanley M. Bergman. (Incorporated by reference to

Exhibit 10.1 Execution Version AMENDED & RESTATED EMPLOYMENT AGREEMENT (?Agreement?) dated as of November 28, 2022 (the ?Effective Date?), by and between HENRY SCHEIN, INC., a Delaware corporation (the ?Company?), and STANLEY M. BERGMAN (?Bergman?). WHEREAS, Bergman is currently Chairman of the Board of Directors and Chief Executive Officer of the Company, and Bergman and the Company previously ha

November 29, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

November 1, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-

November 1, 2022 10-Q

January 20, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 24, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY S

November 1, 2022 EX-99.1

HENRY SCHEIN REPORTS RECORD NON-GAAP THIRD-QUARTER 2022 DILUTED EPS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD NON-GAAP THIRD-QUARTER 2022 DILUTED EPS FINANCIAL RESULTS ? Net sales of $3.

August 2, 2022 EX-99.1

HENRY SCHEIN REPORTS RECORD SECOND-QUARTER 2022 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD SECOND-QUARTER 2022 FINANCIAL RESULTS ? Second-quarter net sales of $3.

August 2, 2022 10-Q

January 20, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 25, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

August 2, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

July 8, 2022 CORRESP

2

July 8, 2022 United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street N.

June 27, 2022 CORRESP

GENERAL BUSINESS:

GENERAL BUSINESS: 1-631-843-5500 FAX: 1-631-843-5680 www.henryschein.com June 27, 2022 VIA ELECTRONIC TRANSMISSION Robert Shapiro Lyn Shenk Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re: Henry Schein, Inc. Form 10-K for the Fiscal Year Ended December 25, 2

June 24, 2022 11-K

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11 -K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

May 25, 2022 SD

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 20, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 3, 2022 EX-99.1

HENRY SCHEIN REPORTS RECORD FIRST-QUARTER

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD FIRST-QUARTER 2022 FINANCIAL RESULTS ? Total first-quarter 2022 net sales of $3.

May 3, 2022 EX-10.1

effective as of May 21, 2020). (Incorporated by reference to Exhibit 10.1 to our Quarterly

Exhibit 10.1 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the ?Agreement?) is made as of [Grant Date] (the ?Grant Date?), by and between Henry Schein, Inc. (the ?Company?) and [Participant Name] (the ?Participant?). Additional country-specific terms and conditions that gov

May 3, 2022 EX-10.3

between us and certain executive officers who are a party thereto (Ronald N. South,

Exhibit 10.3 HENRY SCHEIN, INC. EXECUTIVE CHANGE IN CONTROL PLAN Effective as of May 2, 2022 1. Introduction. The purpose of the Henry Schein, Inc. Executive Change in Control Plan (the ?Plan?) is to provide assurances of specified benefits to executive-level employees of Henry Schein, Inc. (?HSI? or the ?Company?) who are eligible to participate as set forth under the Plan and who are members of

May 3, 2022 10-Q

January 20, 2016

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEI

May 3, 2022 EX-10.2

restated effective as of May 21, 2020). (Incorporated by reference to Exhibit 10.2 to our

Exhibit 10.2 FORM OF RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the ?Agreement?) is made as of [Grant Date] (the ?Grant Date?), by and between Henry Schein, Inc. (the ?Company?) and [Participant Name] (the ?Participant?). Additional country-specific terms and conditions that gov

May 3, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

April 6, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 6, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 4, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Nu

April 4, 2022 EX-99.1

HENRY SCHEIN ANNOUNCES RETIREMENT OF CHIEF ADMINISTRATIVE OFFICER AND APPOINTS CHIEF OPERATING OFFICER

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES RETIREMENT OF CHIEF ADMINISTRATIVE OFFICER AND APPOINTS CHIEF OPERATING OFFICER ? Gerald A. Benjamin will retire as Chief Administrative Officer ? Michael S. Ettinger will be promoted to Chief Operating Officer MELVILLE, N.Y., April 4, 2022 ? Henry Schein, Inc. (Nasdaq: HSIC), the world?s largest provider of health care solutio

February 15, 2022 EX-21.1

List of our Subsidiaries.+

Exhibit 21.1 List of Subsidiaries Subsidiary Jurisdiction of incorporation or organization ACE Surgical Supply Co., Inc.1 Massachusetts BioHorizons, Inc.2 Delaware Camlog USA, Inc.3 Delaware eAssist, Inc.4 Wyoming Exan Enterprises Inc.5 Nevada Handpiece Parts & Repairs, Inc. Delaware Henry Schein Europe, Inc.6 Delaware Henry Schein Global Sourcing, Inc.7 Delaware Henry Schein Latin America Pacific

February 15, 2022 EX-4.5

Description of Securities. (Incorporated by reference to Exhibit 4.5 to our Annual Report

Exhibit 4.5 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Henry Schein, Inc. (?Henry Schein? or the ?Company?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): the Company?s common stock, par value $0.01 per share (?Common Stock?). Description of Com

February 15, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

February 15, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 25, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-27078 HENRY SCHEIN, INC. (

February 15, 2022 EX-99.1

HENRY SCHEIN REPORTS RECORD NON-GAAP FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD NON-GAAP FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS ? Fourth-quarter total net sales of $3.

February 14, 2022 SC 13G/A

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

February 10, 2022 SC 13G/A

HSIC / Henry Schein, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Henry Schein Inc. Title of Class of Securities: Common Stock CUSIP Number: 806407102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??R

February 3, 2022 SC 13G/A

HSIC / Henry Schein, Inc. / Longview Partners (Guernsey) LTD - LONGVIEW PARTNERS (GUERNSEY) LIMITED Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Henry Schein, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) US8064071025 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

January 5, 2022 EX-99.1

HENRY SCHEIN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER AND RELATED SUCCESSION PLAN

Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER AND RELATED SUCCESSION PLAN ? CFO Steven Paladino will retire on April 29, 2022, to be succeeded by Ronald N. South, Henry Schein?s Vice President, Corporate Finance and Chief Accounting Officer ? Mr. Paladino to remain a member of Henry Schein?s Board of Directors and become an adviser to the Company f

January 5, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2022 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File N

December 8, 2021 EX-99.1

HENRY SCHEIN APPOINTS SCOTT SEROTA TO BOARD OF DIRECTORS Former President and CEO of Blue Cross Blue Shield Brings Health Care Expertise

Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN APPOINTS SCOTT SEROTA TO BOARD OF DIRECTORS Former President and CEO of Blue Cross Blue Shield Brings Health Care Expertise MELVILLE, N.Y., December 8, 2021 ? Henry Schein, Inc. (Nasdaq: HSIC), the world?s largest provider of health care solutions to office-based dental and medical practitioners, announced today that Scott Serota has been appointed a

December 8, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

November 2, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-

November 2, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 25, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY S

November 2, 2021 EX-99.1

HENRY SCHEIN REPORTS RECORD THIRD-QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD THIRD-QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS ? Total net sales of $3.

October 21, 2021 EX-10.1

as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as agent

EXHIBIT 10.1 AMENDMENT NO. 7 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 7 TO RECEIVABLES PURCHASE AGREEMENT, dated as of October 20, 2021 (this ?Amendment?), is entered into among HSFR, INC., a Delaware corporation, as seller (the ?Seller?), the TD PURCHASERS (as defined below) and the other PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the ?Purchasers?), the TD PURCHASER AGENT (as de

October 21, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

October 21, 2021 EX-4.2

thereto. (Incorporated by reference to Exhibit 4.2 to our Current Report on Form 8-K filed

EXHIBIT 4.2 HENRY SCHEIN, INC. $50,000,000 3.45% Series 2012-A Senior Notes due January 20, 2024 $50,000,000 3.00% Series 2012-B Senior Notes due December 24, 2024 $50,000,000 3.42% Series 2017-A Senior Notes due June 16, 2027 $50,000,000 3.32% Series 2018-A Senior Notes due January 2, 2028 $75,000,000 2.58% Series 2021-A Senior Notes due June 2, 2033 $500,000,000 (or the Dollar Equivalent in othe

October 21, 2021 EX-4.4

Third Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of

EXHIBIT 4.4 HENRY SCHEIN, INC. $50,000,000 3.42% Series 2017-A Senior Notes due June 16, 2027 $50,000,000 3.32% Series 2018-A Senior Notes due January 2, 2028 $50,000,000 2.35% Series 2020-A Senior Notes due September 2, 2030 $50,000,000 2.48% Series 2021-A Senior Notes due June 2, 2031 $400,000,000 (or the Dollar Equivalent in other Available Currencies) Master Note Facility THIRD AMENDED AND RES

October 21, 2021 EX-4.3

thereto. (Incorporated by reference to Exhibit 4.3 to our Current Report on Form 8-K filed

EXHIBIT 4.3 HENRY SCHEIN INC. NEW YORK LIFE INSURANCE COMPANY $50,000,000 3.09% SERIES B SENIOR NOTES DUE JANUARY 20, 2022 $100,000,000 3.52% SERIES D SENIOR NOTES DUE SEPTEMBER 15, 2029 $50,000,000 2.35% SERIES E SENIOR NOTES DUE SEPTEMBER 2, 2030 $50,000,000 2.48% SERIES F SENIOR NOTES DUE JUNE 2, 2031 $25,000,000 2.58% SERIES G SENIOR NOTES DUE JUNE 2, 2033 $350,000,000 MASTER NOTE FACILITY THI

October 21, 2021 EX-4.1

Multicurrency Private Shelf Agreement, dated as of October 20, 2021, by and among us,

EXHIBIT 4.1 HENRY SCHEIN, INC. $250,000,000 (or the Dollar Equivalent in other Available Currencies) Private Shelf Facility MULTICURRENCY PRIVATE SHELF AGREEMENT Dated October 20, 2021 TABLE OF CONTENTS Page 1. AUTHORIZATION OF NOTES 1 2. SALE AND PURCHASE OF NOTES 2 2.1. Facility 2 2.2. Issuance Period 2 2.3. Request for Purchase 2 2.4. Rate Quotes 3 2.5. Acceptance 3 2.6. Market Disruption 3 2.7

August 23, 2021 EX-10.1

Amended and Restated Revolving Credit Agreement, dated as of August 20, 2021, among us, the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent. (Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 23, 2021.)

Exhibit 10.1 $1,000,000,000 AMENDED AND RESTATED CREDIT AGREEMENT among HENRY SCHEIN, INC., as Parent Borrower, The Other Subsidiary Borrowers from Time to Time Parties Hereto, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK NATIONAL ASSOCIATION, as Syndication Agent, Dated as of August 20, 2021 JPMORGAN CHASE BANK, N.A., and U.S. BANK NATIONAL ASS

August 23, 2021 EX-99.1

HENRY SCHEIN ANNOUNCES NEW $1 BILLION CREDIT FACILITY

Exhibit 99.1 HENRY SCHEIN ANNOUNCES NEW $1 BILLION CREDIT FACILITY MELVILLE, N.Y., August 23, 2021 ? Henry Schein, Inc. (Nasdaq: HSIC), the world?s largest provider of health care products and services to office-based dental and medical practitioners, today announced that it has amended its revolving credit facility, including an increase in the maximum borrowing amount from $750 million to $1 bil

August 23, 2021 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File N

August 3, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

August 3, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 26, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

August 3, 2021 EX-99.1

HENRY SCHEIN REPORTS RECORD SECOND-QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD SECOND-QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS ? Total net sales of $3.

June 25, 2021 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

May 26, 2021 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 17, 2021 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 17, 2021 EX-3.1

(Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed

Exhibit 3.1 THIRD AMENDED AND RESTATED BY-LAWS OF HENRY SCHEIN, INC. ARTICLE I. OFFICES A registered office shall be established and maintained in the State of Delaware as required by law. The Corporation may have an office or offices, either within or without the State of Delaware, at such other place or places as the Board of Directors may from time to time determine or as the business of the Co

May 4, 2021 EX-10.2

Form of 2021 Special Pandemic Recognition Award Restricted Stock Unit Agreement for time-based restricted stock unit awards pursuant to the Henry Schein, Inc. 2020 Stock Incentive Plan (as amended and restated effective as of May 21, 2020). (Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended March 27, 2021 filed on May 4, 2021.)**

1 Form 3 3/21 Exhibit 10.2 FORM OF 2021 SPECIAL PANDEMIC RECOGNITION AWARD RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the ?Agreement?) is made as of [Grant Date] (the ?Grant Date?), by and between Henry Schein, Inc. (the ?Company?) and [Participant Name] (the ?Participant?). Add

May 4, 2021 10-Q

Quarterly Report - THE 1Q21 QUARTERLY 10-Q REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 27, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEI

May 4, 2021 EX-99.1

HENRY SCHEIN REPORTS RECORD FIRST-QUARTER 2021 FINANCIAL RESULTS

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD FIRST-QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS ? Total net sales of $2.

May 4, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

March 30, 2021 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

March 30, 2021 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

March 8, 2021 EX-99.1

HENRY SCHEIN ANNOUNCES REINSTATEMENT OF SHARE REPURCHASE PROGRAM

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES REINSTATEMENT OF SHARE REPURCHASE PROGRAM MELVILLE, N.Y., March 8, 2021 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company has entered into amendments to its private placement facility agreements, which permit t

March 8, 2021 EX-10.1

Incentive Plan (as amended and restated effective as of May 21, 2020). (Incorporated by

Exhibit 10.1 FORM OF OPTION AGREEMENT PURSUANT TO THE HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 21, 2020) THIS AGREEMENT (the ?Agreement?) is made as of [Grant Date] (the ?Grant Date?), by and between Henry Schein, Inc. (the ?Company?) and [Participant Name] (the ?Participant?). Additional country-specific terms and conditions that govern the grant m

March 8, 2021 EX-4.2

dated as of March 5, 2021, by and among us, NYL Investors LLC and each

Exhibit 4.2 Execution Version SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE FACILITY This SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE FACILITY, dated as of March 5, 2021 (this ?Amendment?), is among Henry Schein, Inc., a Delaware corporation (the ?Company?), NYL Investors LLC (as successor in interest to New York Life Investment Management LLC), a Delaware limited lia

March 8, 2021 EX-4.1

Second Amendment to Second Amended and Restated Multicurrency Private Shelf Agreement, dated as of March 5, 2021, by and among the Company, PGIM, Inc. and each Prudential affiliate which becomes party thereto

EX-4.1 2 d131793dex41.htm EX-4.1 Exhibit 4.1 Execution Version SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY PRIVATE SHELF AGREEMENT This SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY PRIVATE SHELF AGREEMENT, dated as of March 5, 2021 (this “Amendment”), is among Henry Schein, Inc., a Delaware corporation (the “Company”), PGIM, Inc., a New Jersey corporation (“Prude

March 8, 2021 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

March 8, 2021 EX-4.3

Metropolitan Life Insurance Company, MetLife Investment Management, LLC

EX-4.3 4 d131793dex43.htm EX-4.3 Exhibit 4.3 Execution Version SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT This SECOND AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT, dated as of March 5, 2021 (this “Amendment”), is among Henry Schein, Inc., a Delaware corporation (the “Company”), Metropolitan Life Insurance Co

February 26, 2021 S-8

- FORM S-8

As filed with the Securities and Exchange Commission on February 26, 2021 Registration No.

February 17, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11

February 17, 2021 EX-99.1

HENRY SCHEIN REPORTS FOURTH QUARTER 2020 FINANCIAL RESULTS

EX-99.1 2 exhibit991.htm PRESS RELEASE FEBRUARY 17, 2021 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH QUARTER 2020 FINANCIAL RESULTS FROM CONTINUING OPERATIONS ● Total net sales growth of 18.6% in fourth quarter 2020 versus prior-year ● Record total net sales growth for second half of 2020 ● GAAP diluted EPS from continuing operations of $0.99 versus prior-year GAAP diluted EPS from

February 17, 2021 10-K

Annual Report - THE 2020 ANNUAL 10-K REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 26, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-27078 HENRY SCHEIN, INC .

February 17, 2021 EX-21.1

List of our Subsidiaries.+

EX-21.1 2 exhibit211.htm EXHIBIT 21.1 Exhibit 21.1 List of Subsidiaries Subsidiary Jurisdiction of incorporation or organization ACE Surgical Supply Co. 1 Massachusetts BioHorizons, Inc. 2 Delaware Camlog USA, Inc. 3 Delaware Exan Enterprises Inc. 4 Nevada General Injectables & Vaccines, Inc. 5 Virginia Handpiece Parts & Repairs, Inc. Delaware Henry Schein Europe, Inc. 6 Delaware Henry Schein Lati

February 16, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

February 16, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Henry Schein, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) US8064071025 (CUSIP Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Henry Schein, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) US8064071025 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

February 10, 2021 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Henry Schein Inc. Title of Class of Securities: Common Stock CUSIP Number: 806407102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ R

February 10, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2021 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File

February 10, 2021 EX-99.1

HENRY SCHEIN ANNOUNCES TWO NEW DIRECTORS Mohamad Ali and Deborah Derby Appointed as Board Members

EX-99.1 2 d120021dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ANNOUNCES TWO NEW DIRECTORS Mohamad Ali and Deborah Derby Appointed as Board Members MELVILLE, N.Y., February 10, 2021 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that Mohamad Ali and Deborah Derby have

November 2, 2020 EX-99.1

HENRY SCHEIN REPORTS RECORD THIRD QUARTER 2020 FINANCIAL RESULTS FROM CONTINUING

-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS RECORD THIRD QUARTER 2020 FINANCIAL RESULTS FROM CONTINUING OPERATIONS ● Internal sales growth in local currencies of 13.

November 2, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - HENRY SCHEIN INC 3Q QUARTERLY 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-

November 2, 2020 EX-10.2

Plan, amended and restated effective as of January 1, 2014. (Incorporated by reference to

Exhibit 10.2 AMENDMENT NUMBER THREE TO THE HENRY SCHEIN, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2014 WHEREAS, Henry Schein, Inc. (the “Company”) maintains the Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and restated effective as of January 1, 2014, and as subsequently amended (the “Plan”); WHEREAS, pursuant to Section 16 o

November 2, 2020 10-Q

Quarterly Report - THE 3Q20 QUARTERLY 10-Q REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 26, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY S

August 12, 2020 EX-10.1

Henry Schein, Inc. 2020 Recovery Performance Plan

EX-10.1 Exhibit 10.1 Management Team Recovery Performance Plan for U.S. Participants Effective as of July 1, 2020 to December 26, 2020 1. Introduction As a member of the management team, you have direct impact on the profitability of Henry Schein, Inc. (the “Company”). To align your interest with that of the Company, you have been nominated to participate in the 2020 Recovery Performance Plan (“RP

August 12, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File N

August 4, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31

August 4, 2020 EX-99.1

HENRY SCHEIN REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS · Q2 GAAP loss per diluted share from continuing operations of $0.

August 4, 2020 EX-10.9

Stanley M. Bergman. (Incorporated by reference to Exhibit 10.9 to our Quarterly Report on

Exhibit 10.9 To: The Compensation Committee of the Board of Directors of Henry Schein, Inc. In connection with the response of Henry Schein, Inc. (“Company”) to the COVID-19 pandemic, on April 3, 2020, I voluntarily and irrevocably waived, effective as of April 6, 2020 (“Effective Date”), 100% of my Base Salary (as defined in that certain Amended and Restated Employment Agreement, dated as of Augu

August 4, 2020 10-Q

Quarterly Report - THE 2Q20 QUARTERLY 10-Q REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 27, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEIN

August 4, 2020 EX-10.7

April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as agent and the

Exhibit 10.7 EXECUTED VERSION LIMITED WAIVER TO TO RECEIVABLES PURCHASE AGREEMENT This LIMITED WAIVER TO RECEIVABLES PURCHASE AGREEMENT, dated as of May 22, 2020 (this “Waiver Agreement”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), HENRY SCHEIN, INC., as initial Servicer (the “Servicer”), THE PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the “Purch

June 26, 2020 11-K

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11 -K (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1943 For the transition period from to Commission File Number: 0-27078 A. Full title of the plan and

June 25, 2020 EX-99.1

HENRY SCHEIN AMENDS AND EXTENDS FINANCING FACILITIES Company Amends and Extends $350 Million Credit Facility and $1 Billion Private Placement Shelf Facilities

EX-99.1 6 d948426dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN AMENDS AND EXTENDS FINANCING FACILITIES Company Amends and Extends $350 Million Credit Facility and $1 Billion Private Placement Shelf Facilities MELVILLE, N.Y., June. 25, 2020 — Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical professionals

June 25, 2020 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

June 25, 2020 EX-4.1

becomes party thereto. (Incorporated by reference to Exhibit 4.1 to our Current Report on Form

EX-4.1 2 d948426dex41.htm EX-4.1 Exhibit 4.1 EXECUTION VERSION FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY PRIVATE SHELF AGREEMENT This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY PRIVATE SHELF AGREEMENT, dated as of June 23, 2020 (this “Amendment”), is among Henry Schein, Inc., a Delaware corporation (the “Company”), PGIM, Inc., a New Jersey corporation (“Prudent

June 25, 2020 EX-4.2

First Amendment to Second Amended and Restated Master Note Facility, dated as of June 23, 2020, by and among the Company, NYL Investors LLC and each New York Life affiliate which becomes party thereto

EX-4.2 Exhibit 4.2 EXECUTION VERSION FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE FACILITY This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE FACILITY, dated as of June 23, 2020 (this “Amendment”), is among Henry Schein, Inc., a Delaware corporation (the “Company”), NYL Investors LLC (as successor in interest to New York Life Investment Management LLC), a Delaware limite

June 25, 2020 EX-4.3

First Amendment to Second Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of June 23, 2020, by and among the Company, Metropolitan Life Insurance Company, MetLife Investment Management, LLC and each MetLife affiliate which becomes party thereto

EX-4.3 4 d948426dex43.htm EX-4.3 Exhibit 4.3 Execution Version FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT, dated as of June 23, 2020 (this “Amendment”), is among Henry Schein, Inc., a Delaware corporation (the “Company”), Metropolitan Life Insurance Comp

June 25, 2020 EX-10.1

dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, lender, as

EX-10.1 5 d948426dex101.htm EX-10.1 Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 6 TO RECEIVABLES PURCHASE AGREEMENT This AMENDMENT NO. 6 TO RECEIVABLES PURCHASE AGREEMENT, dated as of June 22, 2020 (this “Amendment”), is entered into among HSFR, INC., a Delaware corporation, as seller (the “Seller”), THE PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the “Purchasers”), THE PURCHASER AGENTS LISTED

June 22, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

May 27, 2020 SD

- FORM SD 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-27078 11-3136595 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 135 DURYEA ROAD, MELVILLE, NEW YORK 11747 (Address of principal executive offices)

May 26, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Numb

May 26, 2020 EX-10.1

Henry Schein, Inc. 2020 Stock Incentive Plan, as amended and restated effective as of May

EX-10.1 Exhibit 10.1 HENRY SCHEIN, INC. 2020 STOCK INCENTIVE PLAN As Amended and Restated Effective as of May 21, 2020 1. Purposes of the Plan The purposes of this Henry Schein, Inc. 2020 Stock Incentive Plan, as amended and restated effective as of May 21, 2020, are to enable HSI and its Subsidiaries (each as defined herein) to attract, retain and motivate the Key Employees and Consultants (each

May 20, 2020 CORRESP

-

CORRESP GENERAL BUSINESS: 1-631-843-5500 FAX: 1-631-843-5680 www.henryschein.com May 20, 2020 Patrick Kuhn Doug Jones United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street N.E. Washington, D.C. 20549 Re: Henry Schein, Inc. Form 10-K for the Fiscal Year Ended December 28, 2019 Filed February 20, 2020 File No. 000-27078 Dear Sirs: We

May 5, 2020 EX-10.3

Plan, amended and restated effective as of January 1, 2014. (Incorporated by reference to

Exhibit 10.3 AMENDMENT NUMBER TWO TO THE HENRY SCHEIN, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2014 WHEREAS, Henry Schein, Inc. (the “Company”) maintains the Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and restated effective as of January 1, 2014, and as subsequently amended (the “Plan”); WHEREAS, pursuant to Section 16 of

May 5, 2020 10-Q

Quarterly Report - THE 1Q20 QUARTERLY 10-Q REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 28, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27078 HENRY SCHEI

May 5, 2020 EX-10.4

Amendment Number Six to the Henry Schein, Inc. Deferred Compensation Plan.**+

EX-10.4 3 d889896dex104.htm EXHIBIT 10.4 Exhibit 10.4 AMENDMENT NUMBER SIX TO THE HENRY SCHEIN, INC. DEFERRED COMPENSATION PLAN EFFECTIVE AS OF JANUARY 1, 2011 WHEREAS, Henry Schein, Inc. (the “Company”) maintains the Henry Schein, Inc. Deferred Compensation Plan, effective as of January 1, 2011, and as subsequently amended (the “Plan”); WHEREAS, pursuant to Section 8.2 of the Plan, the Board of D

May 5, 2020 CORRESP

-

CORRESP GENERAL BUSINESS: 1-631-843-5500 FAX: 1-631-843-5680 www.henryschein.com May 5, 2020 VIA ELECTRONIC TRANSMISSION Patrick Kuhn Doug Jones Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re: Henry Schein, Inc. Form 10-K for the Fiscal Year Ended December

May 5, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27078 (Commission File Number) 11-31365

May 5, 2020 EX-99.1

HENRY SCHEIN REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS · Q1 GAAP diluted EPS from continuing operations of $0.

May 5, 2020 EX-10.5

Stanley M. Bergman. (Incorporated by reference to Exhibit 10.5 to our Quarterly Report on

Exhibit 10.5 To: The Compensation Committee of the Board of Directors of Henry Schein, Inc. Effective as of April 6, 2020 (“Effective Date”), and in connection with the response of Henry Schein, Inc. (“Company”) to the COVID-19 pandemic, I hereby voluntarily and irrevocably waive 100% of my Base Salary (as defined in that certain Amended and Restated Employment Agreement, dated as of August 8, 201

April 20, 2020 EX-10.2

Second Amendment, dated as of April 17, 2020, among us, the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent. (Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 20, 2020.)

EX-10.2 3 d910136dex102.htm EX-10.2 Exhibit 10.2 SECOND AMENDMENT Second Amendment dated as of April 17, 2020 (this “Amendment”) to the Credit Agreement dated as of April 18, 2017 (as amended by the First Amendment dated as of June 29, 2018 and as further amended, supplemented or otherwise modified from time to time, the “Credit Agreement” and, as amended by this Amendment, the “Amended Credit Agr

April 20, 2020 EX-10.1

Credit Agreement, dated as of April 17, 2020, among us, the several lenders parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, joint lead arranger and joint bookrunner, and U.S. Bank National Association, as joint lead arranger and joint bookrunner. (Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 20, 2020.)

EX-10.1 Exhibit 10.1 $700,000,000 364-DAY CREDIT AGREEMENT among HENRY SCHEIN, INC., as Borrower, The Several Lenders Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, U.S. BANK, NATIONAL ASSOCIATION, as Syndication Agent, JPMORGAN CHASE BANK, N.A. and U.S. BANK, NATIONAL ASSOCIATION, as Joint Lead Arrangers and Joint Bookrunners TD BANK, N.A., ING BANK, N.V., Dublin Branch and M

April 20, 2020 EX-99.1

HENRY SCHEIN ENHANCES LIQUIDITY POSITION WITH NEW CREDIT FACILITY TOTALING $700 MILLION Company Also Amends Existing $750 Million Credit Facility; Total Liquidity Now at $1.7 Billion

EX-99.1 4 d910136dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE HENRY SCHEIN ENHANCES LIQUIDITY POSITION WITH NEW CREDIT FACILITY TOTALING $700 MILLION Company Also Amends Existing $750 Million Credit Facility; Total Liquidity Now at $1.7 Billion MELVILLE, N.Y., April 20, 2020 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental a

April 20, 2020 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2020 Henry Schein, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Nu

April 7, 2020 DEF 14A

HSIC / Henry Schein, Inc. DEF 14A - - DEF 14A

DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Pro

April 7, 2020 DEFA14A

HSIC / Henry Schein, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

April 6, 2020 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2020 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Num

Other Listings
IT:1HSIC € 57.92
MX:HSIC
GB:0L3C US$ 68.73
AT:HSIC
DE:HS2 € 57.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista